1Martinez MR,Nag S,Nieroda CA ,et al.Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver.Cancer,1999,85:1218-1225.
2Schuricht AL,Spitz F,Barbot D ,et al.Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.Am Surg,1998,64: 1043-1049.
3Munzenrider JE.Uveal melanomas: conservation treatment.Hematol Oncol Clin North Am,2001,15:389-402.
4Blasko JC,Wallner k,Grimm PD,et al. Prostate specific antigen based disease control following ultrasound guided 125 I implantation T/T prostate carcinoma. J Urol,1995,54(3):1096-1099
5Critz FA,Tarlton RS,Hollady DA. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer : 125I implant follow by external beam radiation. Cancer,1995,75(4):2385-2391
6Sneed P, Mcdermott MW,Gutin P,etal. Interstitial brachytherapy procedures for brain tumors. Seminars in Surgical Oncology,1997,13:157-166.
7Gaspar LE,Zamorano, LJ,Shamsa F,et al. Permanent125Iodine implants for recurrentmalignant gliomas. Int J Radait Oncol Bio Phys, 1999,43:977-982.
8Halligan JB, Stelzer KJ, Rostomily RC et al. Operation and permanent lowactivity125I brachytherapy for recurrent high-grade astrocytomas.Int J Radait Oncol BioPhys,1996,35:541-547.
9Vikram B. Permanent Iodine-125 boost after teletherapy in primary cancer of thenasopharynx is safe and highly effective :long-term results. Int J Radait oncol Bio Phys,1997,38:1140.
10Matsumoto S, akeda M, Shibuya H, et a1. T1 and T2 squamous cell carcinomas of thefloor of the mouth: Results of brachytherapy mainly using198 Au grains. Int J Radait OncolBio Phys, 1996,34:833-841.
